Merck & Co., Inc. Repayments of Short-term Debt
Merck & Co., Inc. (MRK) reported Repayments of Short-term Debt of $6.00 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfShortTermDebt · last filed 2026-08-07
- Merck & Co., Inc. repayments of short-term debt for fiscal 2023 was $0.00.
- Merck & Co., Inc. repayments of short-term debt for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Merck & Co., Inc. repayments of short-term debt for fiscal 2021 was $3.99B.
| Period end | Repayments of Short-term Debt 6 month | Repayments of Short-term Debt 12 month |
|---|---|---|
| 2026-06-30 | $6.00B 10-Q · filed 2026-08-07 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-07 | |
| 2023-12-31 | $0.00 10-K · filed 2024-02-26 | |
| 2022-12-31 | $0.00 10-K · filed 2024-02-26 | |
| 2021-12-31 | $3.99B 10-K · filed 2024-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |